EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients

Lara Chavaz iD, Léna Royston, Stavroula Masouridi-Levrat, Anne-Claire Mamez, Federica Giannotti, Sarah Morin, Christian Van Delden, Yves Chalandon iD, Dionysios Neofytos iD

Open Forum Infectious Diseases · 04.04.2023 · 10 (4)

DOI: 10.1093/ofid/ofad169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 27.03.2023. Verfasst von Lara Chavaz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this single-center study of 61 allogeneic hematopoietic cell transplant (HCT) recipients receiving letermovir primary cytomegalovirus (CMV) prophylaxis for the first 100 days, we report 23% incidence of clinically significant CMV infection during the first 100 days after letermovir discontinuation, predominately in haploidentical HCT recipients, without any associations with CMV-DNAemia under letermovir.

Schlagwörter

Stichwörter der Autor:innen

allogeneic hematopoietic cell transplant recipients (allo-HCTr)breakthrough infectioncytomegalovirus (CMV)letermovirprophylaxisrisk factors

Autor:innen und Institutionen

  • Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.
  • Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and faculty of Medicine, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Lara Chavaz, Yves Chalandon, Dionysios Neofytos

Zitieren

APA

Chavaz, L., Royston, L., Masouridi-Levrat, S., Mamez, A. C., Giannotti, F., Morin, S., Van Delden, C., Chalandon, Y., & Neofytos, D. (2023). CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients. Open Forum Infectious Diseases, 10(4). https://doi.org/10.1093/ofid/ofad169

Vancouver

Chavaz L, Royston L, Masouridi-Levrat S, Mamez AC, Giannotti F, Morin S, et al. CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients. Open Forum Infectious Diseases. 2023;10(4). doi:10.1093/ofid/ofad169

BibTeX
@article{Chavaz2023,
  author = {Chavaz, Lara and Royston, Léna and Masouridi-Levrat, Stavroula and Mamez, Anne-Claire and Giannotti, Federica and Morin, Sarah and Van Delden, Christian and Chalandon, Yves and Neofytos, Dionysios},
  title = {CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients},
  journal = {Open Forum Infectious Diseases},
  year = {2023},
  volume = {10},
  number = {4},
  doi = {10.1093/ofid/ofad169}
}
Kostenlos starten →